Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Fund Category
Scheme
Your result on : Select A Fund Family   |   Select a Category   |   Select a Scheme
Your are on :  Markets    |  Mutual Fund   |  Scheme Profile
UTI-Healthcare Fund (G)
Summary Info
Fund Name : UTI Mutual Fund
Scheme Name : UTI-Healthcare Fund (G)
AMC : UTI Mutual Fund
Type : Open
Category : Equity - Pharma
Launch Date : 27-May-99
Fund Manager : Kamal Gada
Net Assets:(Rs. cr) 947.26
NAV Graph
NAV Details
NAV Date : 15-Apr-24
NAV [Rs] : 220.65
Buy/Resale Price [Rs] : 0.00
Sell/Repurchase Price [Rs] : 0.00
Entry Load % : Nil
Exit Load % : 1.00% - If redeemed / switched out less than one year from the date of allotment. Nil - If redeemed / switched out greater than or equal to one year from the date of allotment.
Latest Payouts
  Dividends Bonus
Ratio NA NA
Date NA NA
Investment Details
Tax Benefits : NA
Min. Investment(Rs.) : 5000
Increm.Investment(Rs.) : 1000
Performance(%) Date :15-Apr-24
  1 Week 1 Month 3 Month 6 Month 1 Year 3 Year 5 Year Since INC
Scheme Return -1.89 2.01 4.12 19.34 49.04 14.75 20.66 13.28
Category Avg -1.08 1.89 7.24 24.23 52.55 17.38 23.45 19.44
Category Best -0.41 4.34 10.14 27.60 59.68 20.72 27.52 36.99
Category Worst -1.75 -0.31 4.88 20.71 45.50 12.46 18.95 -0.11
Statistical Ratios
What is Beta ?
Beta is a measure of the volatility of the portfolio to that of the index. In simple words it shows the movement of the portfolio in comparison. The Higher the Beta, higher the volatility of the scheme to the index. If its greater than1 , then the portfolio is highly volatile to the movemnts in the index. If the beta is lesser than 1 , then scheme is less volatile to the index and beta which is close to 1 implies that the scheme is closely following the index.
Beta [%] SD [%] Sharpe Ratio [%] Jensons Alpha [%] ER [%]
0.9220 4.3653 0.7447 -0.3196 0.4801
Asset Allocation
Holdings 31-Mar-24
Company Name % Hold
Sun Pharma.Inds. 13.56
Cipla 7.15
Apollo Hospitals 6.88
Ajanta Pharma 5.91
Dr Reddy's Labs 5.49
Fortis Health. 3.55
Krishna Institu. 3.48
Aurobindo Pharma 3.45
Torrent Pharma. 3.16
Suven Pharma 3.15
ERIS Lifescience 2.94
Gland Pharma 2.92
Zydus Lifesci. 2.65
Metropolis Healt 2.36
Divi's Lab. 2.35
P & G Health Ltd 2.33
Ipca Labs. 2.22
Alkem Lab 2.03
Glenmark Pharma. 1.80
Jupiter Life Lin 1.70
Pfizer 1.68
Concord Biotech 1.61
Syngene Intl. 1.58
Caplin Point Lab 1.39
Aster DM Health. 1.34
Marksans Pharma 1.33
Ami Organics 1.27
Alembic Pharma 1.25
Windlas Biotech 1.16
Abbott India 1.15
Orchid Pharma 1.12
Rainbow Child. 1.10
Poly Medicure 1.05
Max Healthcare 0.78
Sequent Scien. 0.76
Vijaya Diagnost. 0.59
Star Health Insu 0.57
Indoco Remedies 0.55
C C I 0.01
TBILL-364D 0.13
Net CA & Others 0.52
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores
Investor Charter
STOCK BROKER DEPOSITORY PARTICIPANTS INVESTOR GRIEVANCES ESCALATION MATRIX
Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)